As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.
23 Analysts have issued a Henry Schein forecast:
23 Analysts have issued a Henry Schein forecast:
Jun '25 |
+/-
%
|
||
Revenue | 12,773 12,773 |
2%
2%
|
|
Gross Profit | 4,002 4,002 |
1%
1%
|
|
EBITDA | 1,030 1,030 |
20%
20%
|
EBIT (Operating Income) EBIT | 777 777 |
26%
26%
|
Net Profit | 389 389 |
11%
11%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Head office | United States |
CEO | Stanley Bergman |
Employees | 25,000 |
Founded | 1932 |
Website | www.henryschein.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.